Navigation Links
Nonlinear Dynamics announces more details of its global partnership with PerkinElmer

Nonlinear Dynamics Ltd, a leading provider of bioinformatics solutions, today announced further details of its global OEM partnership with PerkinElmer, Inc. (NYSE: PKI), a leading provider of drug discovery, life science research and analytical solutions.

As detailed in a press release issued last week, PerkinElmer will distribute Nonlinear's full range of 1D, 2D and array software. However the agreement also represents the formation of an integrated partnership between the two companies, with Nonlinear now formally established as PerkinElmer's principal software partner for all proteomics applications.

Mary Lopez, Business Leader for Analytical Proteomics at PerkinElmer said, "PerkinElmer was eager to establish a single strong proteomics software and bioinformatics partner going into 2005 and beyond. In entering this collaboration with Nonlinear, we are firmly endorsing Nonlinear Dynamics as that partner. The product and corporate synergies between PerkinElmer and Nonlinear made this a natural choice to benefit our customers into the future."

She continued, "PerkinElmer is re-launching its gel imaging strategy this year with ProXPRESS, our new consumables and Nonlinear's software as the centrepieces to that strategy. Our intention is to reaffirm PerkinElmer as the first choice in gel imaging, whether it be for 1D or 2D gels, blots or any other applications."

John Spreadbury, Group Sales and Marketing Director of Nonlinear Dynamics and CEO of Nonlinear USA Inc., added, "Nonlinear has provided PerkinElmer with software for a number of years now and we are very excited by this positive assertion by PerkinElmer of Nonlinear's central role within its proteomics strategy. Together we have a number of new initiatives which we are already working on. We are confident that the extensive fruits of this relationship will continue to benefit the proteomics community for many years to come."


Source:Nonlinear Dynamics

Page: 1

Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
3. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
4. GlycoFi announces the first production of antibodies with human glycosylation in yeast
5. NHGRI announces new sequencing targets
6. CHAVI announces international search for genes affecting HIV response
7. NHGRI announces latest sequencing targets
8. MUHC announces a transplant first in Quebec
9. St. Jude announces breakthrough in eye cancer treatment
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. Researcher uncovers details of how cancer spreads
Post Your Comments:

(Date:11/9/2015)... , Nov. 09, 2015 ... the addition of the "Global Law ... their offering. --> ) ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) has ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... , Oct. 29, 2015  Connected health pioneer, ... driving the explosion of technology-enabled health and wellness, and ... new book, The Internet of Healthy Things ... sensors or smartphones even existed, Dr. Kvedar, vice president, ... of health care delivery, moving care from the hospital ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 Human Longevity, Inc. ... company has acquired Cypher Genomics, Inc., a leading genome ... genomic interpretation software solutions. The San Diego ... HLI including Cypher CEO and Co-founder, Ashley Van Zeeland ... Pediatric Business.  Financial details of the deal were not ...
(Date:11/30/2015)... , Nov. 30, 2015  HUYA Bioscience International, ... China,s pharmaceutical innovations, today announced it has ... Development Fund (KDDF) to foster collaboration between KDDF and ... and commercialization of healthcare products for the global market. ... an important source of new innovative preclinical and clinical ...
(Date:11/30/2015)... 30, 2015  AbbVie, is introducing Good Morning ... a daily routine for managing the life-long condition of ... affect the way the body absorbs it so resources ... daily routine are important. The goal of the new ... manage their hypothyroidism by establishing a daily routine, spirit ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015  Northwest ... biotechnology company developing DCVax® personalized immune therapies for solid ... to adding an additional independent director, and the Company ... investigation of allegations in a recent anonymous internet report ... on both initiatives. Linda Powers stated, ...
Breaking Biology Technology: